{"id":801082,"url":"http://en.wikipedia.org/wiki/BioNTech","text":"BioNTech SE () is a German biotechnology company dedicated to the creation of active immunotherapies for treatments of serious diseases.\nIt researches drugs based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases. In 2020, the company started developing the BNT162b2 vaccine against SARS-CoV-2 with Pfizer and Fosun.","categories":[],"infobox_types":[],"annotations":[{"uri":"Germany","surface_form":"German","offset":20},{"uri":"Biotechnology","surface_form":"biotechnology","offset":27},{"uri":"Immunotherapy","surface_form":"immunotherapies","offset":85},{"uri":"Messenger_RNA","surface_form":"messenger RNA","offset":166},{"uri":"Cancer_immunotherapy","surface_form":"cancer immunotherapies","offset":213},{"uri":"Vaccine","surface_form":"vaccines","offset":240},{"uri":"Infection","surface_form":"infectious","offset":257},{"uri":"Rare_disease","surface_form":"rare diseases","offset":318},{"uri":"Severe_acute_respiratory_syndrome_coronavirus_2","surface_form":"SARS-CoV-2","offset":402},{"uri":"Pfizer","surface_form":"Pfizer","offset":418}]}